Kūʻai wela ʻO CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine/ Monoisopropanolamine (MIPA)

Ke manaʻoʻiʻo mau nei mākou ua hoʻoholo ke ʻano o kekahi i ka maikaʻi o nā huahana, hoʻoholo nā kikoʻī i nā huahana 'kiʻekiʻe kiʻekiʻe, me ka REALISTIC, EFFICIENT AND INNOVATIVE crew spirit for Hot-selling High Quality CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine/ Monoisopropanolamine (MIPA), E hoʻonui mākou i nā ho'āʻo e kōkua i nā mea kūʻai kūʻai kūloko a me ka honua, a e hoʻohua i ka pōmaikaʻi a me ka hui lanakila-lanakila ma waena o mākou.ke kali nei mākou i kāu hui pū ʻana.
Ke manaʻoʻiʻo mau nei mākou e hoʻoholo ke ʻano o kekahi i ka maikaʻi kiʻekiʻe o nā huahana, nā kikoʻī e hoʻoholo i nā huahana 'kiʻekiʻe kiʻekiʻe, me ka REALISTIC, EFFICIENT AND INOVATIVE crew spirit forKina Mipa a me Monoisopropanolamine, Hoʻohui mākou i ka hoʻolālā, hana a me ka hoʻokuʻu aku me ka ʻoi aku o 100 mau limahana akamai, ʻōnaehana hoʻomalu maikaʻi a me ka ʻenehana ʻike. ʻApelika etc.

3′-Amino-2′-hydroxy-[1,1'-bipheny]-3-carboxylic acid ua hoʻohana ʻia ma ke ʻano waena o Eltrombopag.
ʻO Eltrombopag, i hoʻomohala ʻia e GlaxoSmithKline (GSK) ma UK a ma hope i hoʻomohala pū ʻia me Novartis ma Switzerland, ʻo ia ka mea mua a ʻae wale ʻia ka mole liʻiliʻi non peptide TPO receptor agonist ma ka honua.Ua ʻae ʻia ʻo Eltrombopag e ka US FDA ma 2008 no ka mālama ʻana i ka idiopathic thrombocytopenic purpura (ITP), a ma 2014 no ka mālama ʻana i ka anemia aplastic koʻikoʻi (AA).ʻO ia ka lāʻau lapaʻau mua i ʻae ʻia e ka US FDA no ka mālama ʻana iā AA i nā makahiki he 30 i hala iho nei.
Ma December2012, ua apono ka US FDA ia Eltrombopag no ka lapaau ana i ka thrombocytopenia i na ma'i me ka ma'i hepa C (CHC), i hiki i na ma'i hepa C me ka ilihune prognosis ma muli o ka helu platelet ha'aha'a hiki ke ho'omaka a mālama i ka interferon ma muli o ka ma'i ma'i o ka ate.Ma Feberuari 3,2014, ua hoʻolaha ʻo GlaxoSmithKline ua hāʻawi ka FDA i ka hōʻailona lāʻau lapaʻau holomua o Eltrombopag no ka mālama ʻana i ka hemopenia i nā maʻi me ka puke kemika aplastic anemia (SAA) ʻaʻole i pane piha i ka immunotherapy.Ma ʻAukake 24, 2015, ua ʻae ka US FDA iā Eltrombopag no ka mālama ʻana i ka thrombocytopenia i nā pākeke a me nā keiki o 1 makahiki a ʻoi aku me ka thrombocytopenia immune maʻi (ITP) i lawa ʻole ka pane ʻana i nā corticosteroids, immunoglobulins a splenectomy.Ma Ianuali4,2018, ua ʻae ʻia ʻo Eltrombopag e papa inoa ma Kina no ka mālama ʻana i ka thrombocytopenia immune mua (ITP).

Ke manaʻoʻiʻo mau nei mākou ua hoʻoholo ke ʻano o kekahi i ka maikaʻi o nā huahana, hoʻoholo nā kikoʻī i nā huahana 'kiʻekiʻe kiʻekiʻe, me ka REALISTIC, EFFICIENT AND INNOVATIVE crew spirit for Hot-selling High Quality CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine/ Monoisopropanolamine (MIPA), E hoʻonui mākou i nā ho'āʻo e kōkua i nā mea kūʻai kūʻai kūloko a me ka honua, a e hoʻohua i ka pōmaikaʻi a me ka hui lanakila-lanakila ma waena o mākou.ke kali nei mākou i kāu hui pū ʻana.
Kūʻai welaKina Mipa a me Monoisopropanolamine, Hoʻohui mākou i ka hoʻolālā, hana a me ka hoʻokuʻu aku me ka ʻoi aku o 100 mau limahana akamai, ʻōnaehana hoʻomalu maikaʻi a me ka ʻenehana ʻike. ʻApelika etc.